This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (173)

Published on in Vol 5, No 4 (2016): Oct-Dec

A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)

A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)

A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)

Authors of this article:

Nobuko Yamaguchi 1 Author Orcid Image ;   Sonoko Misawa 2 Author Orcid Image ;   Yasunori Sato 3 Author Orcid Image ;   Kengo Nagashima 3 Author Orcid Image ;   Kanako Katayama 1 Author Orcid Image ;   Yukari Sekiguchi 2 Author Orcid Image ;   Yuta Iwai 2 Author Orcid Image ;   Hiroshi Amino 2 Author Orcid Image ;   Tomoki Suichi 2 Author Orcid Image ;   Takanori Yokota 4 Author Orcid Image ;   Yoichiro Nishida 4 Author Orcid Image ;   Nobuo Kohara 5 Author Orcid Image ;   Koichi Hirata 6 Author Orcid Image ;   Kazutoshi Nishiyama 7 Author Orcid Image ;   Ichiro Yabe 8 Author Orcid Image ;   Ken-Ichi Kaida 9 Author Orcid Image ;   Norihiro Suzuki 10 Author Orcid Image ;   Hiroyuki Nodera 11 Author Orcid Image ;   Shoji Tsuji 12 Author Orcid Image ;   Haruki Koike 13 Author Orcid Image ;   Jun-Ichi Kira 14 Author Orcid Image ;   Hideki Hanaoka 1 Author Orcid Image ;   Susumu Kusunoki 15 Author Orcid Image ;   Satoshi Kuwabara 2 Author Orcid Image ;   JET-GBS Group 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15
Article Authors Cited by (11) Tweetations (3) Metrics
Nobuko Yamaguchi 1, BSc;  Sonoko Misawa 2, PhD, MD;  Yasunori Sato 3, PhD;  Kengo Nagashima 3, PhD;  Kanako Katayama 1, MSc;  Yukari Sekiguchi 2, PhD, MD;  Yuta Iwai 2, PhD, MD;  Hiroshi Amino 2, MD;  Tomoki Suichi 2, MD;  Takanori Yokota 4, PhD, MD;  Yoichiro Nishida 4, PhD, MD;  Nobuo Kohara 5, PhD, MD;  Koichi Hirata 6, PhD, MD;  Kazutoshi Nishiyama 7, PhD, MD;  Ichiro Yabe 8, PhD, MD;  Ken-Ichi Kaida 9, PhD, MD;  Norihiro Suzuki 10, PhD, MD;  Hiroyuki Nodera 11, MD;  Shoji Tsuji 12, PhD, MD;  Haruki Koike 13, PhD, MD;  Jun-Ichi Kira 14, PhD, MD;  Hideki Hanaoka 1, PhD, MD;  Susumu Kusunoki 15, PhD, MD;  Satoshi Kuwabara 2, PhD, MD;   JET-GBS Group 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15

1 Reseach and Education Center of Health Sciences, Gunma University Graduate School of Health Sciences , Gunma , JP

2 Department of Neurology, Chiba University Graduate School of Medicine , Chiba , JP

3 Department of Global Clinical Research, Chiba University Graduate School of Medicine , Chiba , JP

4 Department of Neurology and Neurological Science, Tokyo Medical and Dental University , Tokyo , JP

5 Department of Neurology, Kobe City Medical Centre General Hospital , Kobe , JP

6 Department of Neurology, Dokkyo Medical University , Tochigi , JP

7 Department of Neurology, Kitasato University School of Medicine , Kanagawa , JP

8 Department of Neurology, Hokkaido University Graduate School of Medicine , Sapporo , JP

9 Division of Neurology, Department of Internal Medicine, National Defense Medical College, Saitama , JP

10 Department of Neurology, Keio University School of Medicine , Tokyo , JP

11 Department of Clinical Neuroscience, Graduate School of Medical Sciences, Tokushima University, Tokushima , JP

12 Department of Neurology, The University of Tokyo Graduate School of Medicine , Tokyo , JP

13 Department of Neurology, Nagoya University Graduate School of Medicine , Nagoya , JP

14 Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka , JP

15 Department of Neurology, Faculty of Medicine, Kindai University, Osaka-Sayama , JP

Corresponding Author: